Loading profile…

Loading activity…

World & Business

Home
Technology
Gaming
Entertainment
World & Business
Science
Sports
AI

Home
Technology
Gaming
Entertainment
World & Business
Science
Sports
AI

sumedico.com (@sumedico) · Digg

sumedico.com

@sumedico

🫀Salud + Bienestar + Noticias 📲 TikTok • Instagram • Facebook

following
followers

Featured in

Science

Phase 3 trial: Adding Moderna-Merck mRNA treatment to pembrolizumab cut recurrence-or-death risk 42% after high-risk melanoma surgery

The 1,137-patient study tested personalized treatment intismeran alongside pembrolizumab after surgery for high-risk melanoma.

80123456789

3 Sources, 8d ago, updated 8d ago

Connections

@sumedico